Hound Partners, LLC Bio N Tech Se Transaction History
Hound Partners, LLC
- $253 Million
- Q4 2024
A detailed history of Hound Partners, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Hound Partners, LLC holds 100,000 shares of BNTX stock, worth $10.1 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$10.1 Million% of portfolio
0.47%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
365Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$827 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$444 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$432 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$191 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$182 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...